Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes. Drugs (Pharmaceuticals), Regulation and Deregulation of Industry, Appointments and Executive Changes, Vaccination and Immunization, United States Politics and Government, Presidential Election of 2024, Presidential Transition (US), Prices (Fares, Fees and Rates), Lobbying and Lobbyists, Stocks and Bonds, Coronavirus (2019-nCoV), Dietary Supplements and Herbal Remedies, Biotechnology and Bioengineering, Health Insurance and Managed Care, Medicare, Politics and Government, Medicine and Health, Medicaid, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Food and Drug Administration, Health and Human Services Department, Merck & Company Inc, Moderna Inc, Pfizer Inc, Republican Party, Biden, Joseph R Jr, Kennedy, Robert F Jr, Makary, Marty, Nesheiwat, Janette, Oz, Mehmet C, Weldon, David (1953- ), Trump, Donald J Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes. NYT > Business